JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 77 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6,518 | +66.7% | 3,523 | 0.0% | 0.00% | – |
Q4 2022 | $3,911 | -51.1% | 3,523 | 0.0% | 0.00% | – |
Q3 2022 | $8,000 | -38.5% | 3,523 | -20.2% | 0.00% | – |
Q2 2022 | $13,000 | -27.8% | 4,417 | +68.0% | 0.00% | – |
Q1 2022 | $18,000 | -18.2% | 2,629 | 0.0% | 0.00% | – |
Q4 2021 | $22,000 | +10.0% | 2,629 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | +11.1% | 2,629 | 0.0% | 0.00% | – |
Q2 2021 | $18,000 | +12.5% | 2,629 | +73.0% | 0.00% | – |
Q1 2021 | $16,000 | +45.5% | 1,520 | 0.0% | 0.00% | – |
Q4 2020 | $11,000 | -8.3% | 1,520 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -20.0% | 1,520 | -28.5% | 0.00% | – |
Q2 2020 | $15,000 | +50.0% | 2,126 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | -60.0% | 2,126 | -29.3% | 0.00% | – |
Q4 2019 | $25,000 | +150.0% | 3,005 | 0.0% | 0.00% | – |
Q3 2019 | $10,000 | -33.3% | 3,005 | 0.0% | 0.00% | – |
Q2 2019 | $15,000 | -21.1% | 3,005 | 0.0% | 0.00% | – |
Q1 2019 | $19,000 | +171.4% | 3,005 | +54.8% | 0.00% | – |
Q4 2018 | $7,000 | -46.2% | 1,941 | 0.0% | 0.00% | – |
Q3 2018 | $13,000 | -13.3% | 1,941 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | -72.2% | 1,941 | -19.3% | 0.00% | – |
Q1 2018 | $54,000 | +25.6% | 2,404 | -28.3% | 0.00% | – |
Q4 2017 | $43,000 | +2.4% | 3,354 | +23.4% | 0.00% | – |
Q3 2017 | $42,000 | +100.0% | 2,718 | +75.2% | 0.00% | – |
Q2 2017 | $21,000 | -22.2% | 1,551 | +26.1% | 0.00% | – |
Q1 2017 | $27,000 | – | 1,230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|